Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508378 · ClinicalTrials.gov registry record
Chemotherapy-Related Toxicities In Ovarian Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 288
- Enrollment target
NCT00508378: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00508378 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508378 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
Primary Objectives: 1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy. * To compare preferences of women with ovarian cancer to preferences of their clinical caregivers. * To compare preferences of women with ovarian cancer to preferences of their familial caregivers. * To compare preferences of women with ovarian cancer to preferences of a women in the control group. 2. To prospectively collect quality of life data from women with ovarian cancer. 3. To prospectively collect symptom assessment data from women with ovarian cancer.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2001-01 |
| Est. Completion | 2020-11-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508378
The ClinicalTrials.gov registry entry for NCT00508378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00508378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00508378 about?
NCT00508378 is a clinical study titled "Chemotherapy-Related Toxicities In Ovarian Cancer Patients". Primary Objectives: 1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy. * To compare preferences of women with ovarian cancer to preferences of their clinical caregivers. *...
What is the current status of trial NCT00508378?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2001-01. Estimated completion is 2020-11-03.
What interventions are being tested in trial NCT00508378?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508378?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.